ArticleOncoimmunology

Combined chemotherapy and allogeneic human Vγ9Vδ2 T lymphocyte-immunotherapies efficiently control the development of human epithelial ovarian cancer cells

Noémie Joalland et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.